Currencies and equities traded higher on the back of better than expected economic data and reports from Russia that they’ve won the global vaccine race. While Russia announced the world’s first approved vaccine it has not finished phase 3 trials which the World Health Organization deems essential for statistical accuracy. There are currently 8 other vaccines in phase 3 trials from the US, US/UK, Germany and China. Nonetheless, pharmaceutical companies are getting close and the single most important game changer for the global economy could be right around the corner. The persistent gains in stocks reflects the ... (full story)